Is Vaxfab Enterp. overvalued or undervalued?

As of 29 September 2025, Vaxfab Enterprises has moved from an expensive to an attractive valuation grade. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE ratio of 27.85, an EV to EBITDA of 27.19, and a Price to Book Value of 2.07, which suggest a more favorable valuation compared to its peers.
In comparison to its industry peers, Vaxfab's PE ratio is significantly lower than Elitecon International's 467.91 and MMTC's 136.94, both of which are categorized as very expensive. Additionally, Vaxfab's PEG ratio stands at 0.00, indicating potential for growth at a reasonable price. Notably, the company has outperformed the Sensex significantly over the past year, with a stock return of 314.38% compared to the Sensex's decline of 6.08%.